Yongan Pharmaceutical predicts a decline in net profits for Q1 due to COVID-19
On 16 April, Qianjiang Yongan Pharmaceutical Co., Ltd. (Yongan Pharmaceutical) released a forecast for its performance for Q1 2020, showing that the company expects a net profit attributable to shareholders of listed companies to be USD0.70 million&m...
Amino Acids China E-News 202004